SCHEDULE 13G/A

Maze Therapeutics Inc

Common Stock - par value $0.001 per share · CUSIP: 578784100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Frazier Life Sciences Public Fund, L.P.

  Shares: 4,342,266.00 · Class: 9.0%

• FHMLSP, L.P.

  Shares: 4,342,266.00 · Class: 9.0%

• FHMLSP, L.L.C.

  Shares: 4,342,266.00 · Class: 9.0%

• Frazier Life Sciences X, L.P.

  Shares: 75,982.00 · Class: 0.2%

• FHMLS X, L.P.

  Shares: 75,982.00 · Class: 0.2%

• FHMLS X, L.L.C.

  Shares: 75,982.00 · Class: 0.2%

• Frazier Life Sciences XI, L.P.

  Shares: 149,026.00 · Class: 0.3%

• FHMLS XI, L.P.

  Shares: 149,026.00 · Class: 0.3%

• FHMLS XI, L.L.C.

  Shares: 149,026.00 · Class: 0.3%

• Frazier Life Sciences XII, L.P.

  Shares: 0.00 · Class: 0.0%

• FHMLS XII, L.P.

  Shares: 0.00 · Class: 0.0%

• FHMLS XII, L.L.C.

  Shares: 0.00 · Class: 0.0%

• James N. Topper

  Shares: 75,982.00 · Class: 0.2%

• Patrick J. Heron

  Shares: 75,982.00 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.